Compare RNA & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | PEBK |
|---|---|---|
| Founded | 2012 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.6M | 218.4M |
| IPO Year | 2025 | 2012 |
| Metric | RNA | PEBK |
|---|---|---|
| Price | $13.37 | $43.14 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $69.26 | N/A |
| AVG Volume (30 Days) | ★ 205.5K | 34.6K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | N/A | ★ 21.48 |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | N/A |
| P/E Ratio | ★ N/A | $54.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.40 | $26.81 |
| 52 Week High | $73.06 | $45.78 |
| Indicator | RNA | PEBK |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 53.95 |
| Support Level | $13.06 | $41.32 |
| Resistance Level | $14.05 | $45.78 |
| Average True Range (ATR) | 0.49 | 1.49 |
| MACD | 0.19 | -0.09 |
| Stochastic Oscillator | 82.06 | 37.47 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.